trial · primary record
Nanoliposomal Irinotecan
Advanced Biliary Tract Cancer
| Phase | Phase 2 |
|---|---|
| Status | ACTIVE |
| Sponsor | Unknown |
| Enrolment | 48 |
| Primary completion | 2026-12-31 |
| Primary endpoint | The Efficacy of Fluorouracil, Leucovorin, and Nanoliposomal Irinotecan in Advanced Biliary Tract Cancers Following Progression on or Intolerance of Gemcitabine and Platinum Chemotherapy. |
| Registry ID | NCT04005339 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-28T02:31:10.739Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT04005339
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.